All AbMole products are for research use only, cannot be used for human consumption.
Crenezumab (MABT 5102A; RG 7412) is a fully humanized anti-Aβ monoclonal antibody that binds multiple forms of Aβ, such as soluble, oligomeric and fibrillar, for use in Alzheimer's disease research.
| CAS Number | 1095207-05-8 |
| Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |
[4] Dennis J Selkoe, et al. EMBO Mol Med. The amyloid hypothesis of Alzheimer's disease at 25 years
| Related Amyloid Products |
|---|
| Sabirnetug
Sabirnetug is a humanized IgG2κ antibody targeting the Amyloid-β A4 precursor protein. |
| BSB
BSB is a Congo red-derived fluorescent probe. |
| MCAAD-3
MCAAD-3 is a near-infrared Aβ imaging probe with blood-brain barrier penetrability. |
| Glutaminyl Cyclase Inhibitor 1
Glutaminyl Cyclase Inhibitor 1 is a glutaminyl cyclase inhibitor with an IC50 of 0.5 μM. |
| Hoechst 34580 tetrahydrochloride
Hoechst 34580 tetrahydrochloride is a marker dye in Hoechst series. |
All AbMole products are for research use only, cannot be used for human consumption or veterinary use. We do not provide products or services to individuals. Please comply with the intended use and do not use AbMole products for any other purpose.
Products are for research use only. Not for human use. We do not sell to patients.
© Copyright 2010-2024 AbMole BioScience. All Rights Reserved.
